ZIOPHARM Reports Second-Quarter 2016 Financial Results and Provides Update on Recent Activities
Aug 09, 2016 20:01 pm UTC| Business
BOSTON, Aug. 09, 2016 -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced financial results for the second quarter ended June 30, 2016, and provided an update on the Company’s recent activities. "ZIOPHARM had a...
Editas Medicine Announces Second Quarter 2016 Results and Update
Aug 09, 2016 20:01 pm UTC| Business
Exclusive license to high-fidelity Cas9 and Cas9 PAM variants from Massachusetts General Hospital further advances leading genome editing platform Strategic partnership with Adverum to explore delivery of genomic...
Coherus BioSciences Reports Second Quarter 2016 Financial and Operating Results
Aug 09, 2016 20:01 pm UTC| Business
REDWOOD CITY, Calif., Aug. 09, 2016 -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today reported financial results and reviewed corporate events for the second quarter ended June 30, 2016. Corporate Highlights for the...
Ohr Pharmaceutical Reports Third Quarter 2016 Financial and Business Results
Aug 09, 2016 20:01 pm UTC| Business
NEW YORK, Aug. 09, 2016 -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today reported results for its third quarter ended June 30, 2016. “The start of the Phase 3...
Endocyte to Present at the 2016 Wedbush PacGrow Healthcare Conference
Aug 09, 2016 20:01 pm UTC| Business
WEST LAFAYETTE, Ind., Aug. 09, 2016 -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy, today announced that the...
HTG Molecular Diagnostics Reports Second Quarter 2016 Results
Aug 09, 2016 20:01 pm UTC| Business
TUCSON, Ariz., Aug. 09, 2016 -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM), a provider of instruments and reagents for molecular profiling applications, today reported financial results for the three and six month...
Zogenix Provides Corporate Update and Reports Second Quarter 2016 Financial Results
Aug 09, 2016 20:01 pm UTC| Business
EMERYVILLE, Calif., Aug. 09, 2016 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today provided a corporate update...